Aplicación YC de Digistain
Digistain pasó por Y Combinator en el batch Summer 2021 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.
- Batch YC
- Summer 2021
- Industria
- HealthcareDiagnostics
- Tamaño del equipo
- 40
- Estado
- Active
- Lanzado
- 2021
Fundadores
Hemmel AmraniaFounder
Chris PhillipsFounder
Lo que hace Digistain
In the global fight against breast cancer, Digistain stands at the forefront, offering a beacon of hope to millions. Our journey began at Imperial College London, where ground-breaking research gave birth to a technology poised to revolutionize breast cancer diagnostics. The Challenge: Every year, breast cancer affects 2.3 million individuals globally. Post-surgery, 60% of patients are advised to undergo genomic testing, an expensive and time-consuming process monopolized by a single lab in the U.S., costing around $4,000 and taking nearly two months. Consequently, only 5% undergo this vital testing. The rest, unable to access this crucial diagnostic step, often resort to chemotherapy - a treatment that, in one in four cases, is more harmful than the cancer itself. Our Solution: Digistain addresses this critical gap. Our technology transforms the current diagnostic process by enabling hospitals to analyze patient samples in-house using existing equipment, supplemented with our innovative technology. This approach offers near-instantaneous decision-making data, a stark contrast to the existing month-long waits. Central to our technology is a proprietary algorithm that identifies a unique spectral fingerprint of the tumour in the infrared spectrum, providing a personalized risk score. This score guides oncologists in selecting the most effective, individualized treatment plans, potentially reducing unnecessary chemotherapy and its harmful side effects. Impact and Potential: Our solution not only challenges the status quo in technology but also in accessibility. In a landmark government-commissioned study, Digistain demonstrated clinical evidence on par with the market leader, but at a fraction of the cost and time. Already making waves in clinical practice globally, with insurance reimbursement at leading cancer centers, our technology represents a paradigm shift in cancer care. Recognized by the Institute of Physics, the Royal Society, and Imperial College for our innovative contributions, and supported by entities like the NHS, Y Combinator, and the European Investment Bank, Digistain is more than a company - it’s a movement towards equitable, effective cancer treatment. With the potential to democratize access to life-saving diagnostics, Digistain is not just envisioning a better future for cancer patients; we are actively creating it.
Aplicación YC de Digistain, reconstruida
Solicitud de Y Combinator
Digistain, batch Summer 2021. Las preguntas reales del formulario, respondidas con datos públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Digistain
Pioneering Breast Cancer Diagnostics
We built a medical device and software that allows hospitals to analyze breast cancer tissue samples on-site. Our product uses infrared spectroscopy combined with a proprietary algorithm to identify a tumour's spectral fingerprint and generate a personalized risk score. This helps oncologists decide on the best treatment quickly, avoiding expensive, slow genomic tests.
We live in London, England, and the company is based here. After YC, we'll continue to operate from London.
We are based in London because our technology originated at Imperial College London, and much of our early clinical work and validation has been done here. Staying close to NHS partners and research institutions is critical for clinical adoption.
21 respuestas más en la aplicación completa
están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.
Preguntas Frecuentes
¿Es esta la aplicación YC real de Digistain?
No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Digistain (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Digistain se presentaría a YC, no el texto que enviaron.
¿En qué batch de YC estuvo Digistain?
Digistain formó parte del batch Summer 2021 de Y Combinator.
¿Quién fundó Digistain?
Digistain fue fundado por Hemmel Amrania, Chris Phillips.
¿A qué se dedica Digistain?
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
¿Cómo leo la aplicación completa reconstruida?
Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Digistain, y de cada otro batch de YC, está en YC Insights.
Más startups de YC como Digistain
